Literature DB >> 24037225

Can optimal drug dosing during ECMO improve outcomes?

Kiran Shekar1, John F Fraser, Jason A Roberts.   

Abstract

Mesh：

Year:  2013        PMID： 24037225     DOI： 10.1007/s00134-013-3080-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation.

Authors:  Kiran Shekar; John F Fraser; Maree T Smith; Jason A Roberts
Journal:  J Crit Care       Date:  2012-04-18       Impact factor: 3.425

Review 2.  What is new in extracorporeal membrane oxygenation for ARDS in adults?

Authors:  Darryl Abrams; Daniel Brodie; Alain Combes
Journal:  Intensive Care Med       Date:  2013-08-01       Impact factor: 17.440

3.  The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation.

Authors:  Kiran Shekar; Jason A Roberts; Maree T Smith; Yoke L Fung; John F Fraser
Journal:  BMC Anesthesiol       Date:  2013-03-21       Impact factor: 2.217

4.  ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.

Authors:  Kiran Shekar; Jason A Roberts; Susan Welch; Hergen Buscher; Sam Rudham; Fay Burrows; Sussan Ghassabian; Steven C Wallis; Bianca Levkovich; Vin Pellegrino; Shay McGuinness; Rachael Parke; Eileen Gilder; Adrian G Barnett; James Walsham; Daniel V Mullany; Yoke L Fung; Maree T Smith; John F Fraser
Journal:  BMC Anesthesiol       Date:  2012-11-28       Impact factor: 2.217

5.  Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation.

Authors:  Kiran Shekar; Jason A Roberts; Charles I Mcdonald; Stephanie Fisquet; Adrian G Barnett; Daniel V Mullany; Sussan Ghassabian; Steven C Wallis; Yoke L Fung; Maree T Smith; John F Fraser
Journal:  Crit Care       Date:  2012-10-15       Impact factor: 9.097
  5 in total
  3 in total

Review 1.  Designing drug regimens for special intensive care unit populations.

Authors:  Brian L Erstad
Journal:  World J Crit Care Med       Date:  2015-05-04

2.  Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.

Authors:  Jan J De Waele; S Carrette; M Carlier; V Stove; J Boelens; G Claeys; I Leroux-Roels; E Hoste; P Depuydt; J Decruyenaere; A G Verstraete
Journal:  Intensive Care Med       Date:  2013-12-20       Impact factor: 17.440

3.  Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.

Authors:  Kiran Shekar; Jason A Roberts; Adrian G Barnett; Sara Diab; Steven C Wallis; Yoke L Fung; John F Fraser
Journal:  Crit Care       Date:  2015-12-15       Impact factor: 9.097
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.